Clinical study of a CT evaluation model combined with serum CA125 in predicting the treatment of newly diagnosed advanced epithelial ovarian cancer

Table 2 Clinicopathological factors in the NACT + IDS and PDS groups of patients grouped according to the New Scoring System

Clinicopathological factors	Groups with score < 5			Groups with score ≥ 5
Clinicopathological factors	NACT + IDS	PDS	p	NACT + IDS	PDS	p
Age (y)	(53.16 ± 9.40)	(53.64 ± 10.79)	0.818	(52.94 ± 10.16)	(55.77 ± 10.39)	0.176
Stage
III	38	40	0.343	40	39	0.876
IV	11	7	0.343	10	9	0.876
Histology
Serous	42	41	0.970	44	41	0.819
Mucous	6	5		5	5
Endometrioid	1	1		1	2
Grade
G1	15	19	0.598	16	19	0.448
G2	4	3		3	5
G3	30	25		31	24

NACT + IDS neoadjuvant chemotherapy and interval debulking surgery, PDS primary debulking surgery

ISSN: 1757-2215